Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Pep2-8

(Synonyms: Pep 2-8) Copy Product Info
🥰Excellent

Synonyms: Pep 2-8

Catalog No. TP1881 Copy Product Info
Purity: 97.24%
🥰Excellent
Pep2-8 specifically inhibits PCSK9 activity with a KD of 0.7 μM and an IC50 of 1.4 μM.
Pep2-8
Cas No. 1541011-97-5
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$109-In Stock
5 mg$247-In Stock
10 mg$400-In Stock
25 mg$668-In Stock
50 mg$939-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.24%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Pep2-8 specifically inhibits PCSK9 activity with a KD of 0.7 μM and an IC50 of 1.4 μM.
Targets & IC50
PCSK9:0.7 μM (Kd), PCSK9:1.4 μM
In vitro
Methods:
Molecular binding experiments were conducted to verify the binding effect between Pep2-8 and C-terminally truncated PCSK9. A lipid metabolism damage model was established by treating HepG2 cells with PCSK9, and after treatment with 50 μM Pep2-8, the changes in the low-density lipoprotein (LDL) uptake capacity of the cells were detected.
Results:
Pep2-8 could specifically bind to the C-terminally truncated PCSK9. At a working concentration of 50 μM, Pep2-8 effectively reversed the abnormal cell function induced by PCSK9, restoring the LDL uptake capacity of HepG2 cells to approximately 90% of that in the control group [1].
In vivo
Methods:
The binding ability between peptide Pep2-8 and C-terminally truncated PCSK9 was explored. HepG2 cells were treated with PCSK9 to induce functional damage, then treated with 50 μM Pep2-8, and the recovery of LDL uptake function of the cells was detected.
Results:
Pep2-8 could specifically bind to the C-terminally truncated PCSK9 in a targeted manner. After intervention with 50 μM Pep2-8, the LDL uptake capacity of HepG2 cells damaged by PCSK9 was significantly recovered, reaching approximately 90% of the activity of the normal control group [1].
SynonymsPep 2-8
Chemical Properties
Molecular Weight1715.85
FormulaC83H110N16O24
Cas No.1541011-97-5
Smiles[H][C@](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(C)=O)[C@@H](C)O)C(C)C)([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C(C)C)C(N)=O
Relative Density.1.357 g/cm3 (Predicted)
SequenceAc-Thr-Val-Phe-Thr-Ser-Trp-Glu-Glu-Tyr-Leu-Asp-Trp-Val-NH₂
Sequence ShortTVFTSWEEYLDWV
Storage & Solubility Information
StorageKeep away from moistureKeep away from direct sunlight Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
PBS (pH 7.4): 2 mg/mL (1.17 mM), Sonication is recommended.
DMSO: 80 mg/mL (46.62 mM)
Solution Preparation Table
PBS (pH 7.4)/DMSO
1mg5mg10mg50mg
1 mM0.5828 mL2.9140 mL5.8280 mL29.1401 mL
DMSO
1mg5mg10mg50mg
5 mM0.1166 mL0.5828 mL1.1656 mL5.8280 mL
10 mM0.0583 mL0.2914 mL0.5828 mL2.9140 mL
20 mM0.0291 mL0.1457 mL0.2914 mL1.4570 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Keywords

Related Tags: Pep2-8 chemical structure | Pep2-8 in vivo | Pep2-8 in vitro | Pep2-8 formula | Pep2-8 molecular weight